bsdcorp8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  February 6, 2013
 
BSD MEDICAL CORPORATION
 
(Exact name of registrant as specified in its charter)
 
Delaware
0-10783
75-1590407
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

2188 West 2200 South
 
Salt Lake City, Utah 84119
 
(Address of principal executive offices, including Zip Code)
 
Registrant’s telephone number, including area code:  (801) 972-5555
 
N/A
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 
Item 5.07 Submission of Matters to a Vote of Security Holders.
 
On February 6, 2013, BSD Medical Corporation (the “Company”) held its 2013 Annual Meeting of Stockholders (“Annual Meeting”).  The matters voted on and the results of the votes were as follows:

1.  The stockholders elected seven members to the Board of Directors to serve until the next annual meeting or until their successors are duly elected and qualified.  The votes regarding this proposal were as follows:

 
Shares For
Withheld
Broker Non-Vote
Timothy C. McQuay
11,090,884
115,773
11,102,145
Harold R. Wolcott
11,079,721
126,936
11,102,145
Gerhard W. Sennewald
11,093,755
112,902
11,102,145
Michael Nobel
11,094,921
111,736
11,102,145
Douglas P. Boyd
10,585,521
621,136
11,102,145
Steven G. Stewart
11,089,521
117,136
11,102,145
Damian E. Dupuy
11,079,318
127,339
11,102,145
 
2.  The stockholders approved, on an advisory basis, the compensation of the named executive officers of the Company.  The votes regarding this proposal were as follows:
 
Shares For
Shares Against
Abstain
Broker Non-Vote
10,756,242
366,921
83,494
11,102,145
       
 
3.  The stockholders ratified the selection of Tanner LLC as the Company’s independent registered public accountants for the fiscal year ending August 31, 2013.  The votes regarding this proposal were as follows:
 
Shares For
Shares Against
Abstain
20,221,979
1,973,011
113,812
     

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BSD MEDICAL CORPORATION
  
Date:  February 8, 2013
    
 
By:  /s/ William S. Barth
  
 
Name:  William S. Barth
  
 
Title:    Chief Financial Officer